BioGenerator

BioGenerator is the investment arm of BioSTL.

BioGenerator produces a sustained pipeline of successful bioscience companies and entrepreneurs in St. Louis by creating, growing and investing in promising new enterprises.

BioGenerator is a nonprofit subsidiary of BioSTL, which advances St. Louis’ prosperity by cultivating a thriving bioscience sector, building regional capacity to capitalize on St. Louis’ world class medical and plant biosciences.

Office
CIC @ CET
20 South Sarah Street
St. Louis, MO 63108

Follow Lewis & Clark Ventures
Twitter: @BioGeneratorSTL
LinkedIn: BioGenerator
Blog: biogenerator.org/news
Website: BioGenerator.org

Galera Therapeutics Raises $150 Million to Advance “Breakthrough Therapy” for Debilitating Cancer Side Effect

Galera Therapeutics, Inc., a clinical-stage drug discovery company, whose research and development is based in St. Louis, has announced that it has secured $150 million in a joint, oversubscribed Series C financing and royalty...

A “No” from Arch Grants Isn’t a “No” to Your Business

August saw the finalist pitch day of the Arch Grants Global Startup Competition, which constitutes the final round of selection where an external panel of judges will decide who will receive the $50,000 equity...
BioGenerator

Local Immunotherapy Startup Attracts $3 Million Investment

St. Louis-based startup Unleash Immuno Oncolytics, which has developed viral-based biologics to attack cancerous tumors, has attracted a major investment from publicly-traded Japanese company Oncolys BioPharma. Unleash is an immunotherapy company that develops genetically-engineered adenoviruses...

SentiAR Scored A Major Milestone In Federal Grant Peer Review Process

What do you think of when you think of augmented reality? Yep, finding Pokemon in the Missouri Botanical Garden. The flagship example of a successful augmented reality startup is Niantic, the makers of Pokemon...
SentiAR

SentiAR Awarded $2.2 Million Federal Grant to Advance Augmented Reality Device for Cardiologists

SentiAR will receive $2.2 million of non-dilutive milestone installments to advance its platform. Using the SentiAR technology, through the Microsoft head-up display, physicians can view, measure, and manipulate real-time holographic images of the patient’s...

St Louis Startup Boom Was 20 Years In The Making

St Louis’ current position as a global leader in plant science and BioTech, didn’t happen overnight. Instead, careful planning over the course of two decades laid the foundation for the booming startup ecosystem in...
BioGenerator

BioGenerator Wins $300K Federal Grant to Build Bioscience Companies In St. Louis

BioGenerator, the investment arm of BioSTL, has won a $300,000 grant from the U.S. Department of Commerce to capitalize on its retooled investment strategy. That strategy is focused around quickly scaling companies to attract...
AgIdea

Biotech Crop Startup Plastomics Raises Investment For Early Seed Round

Plastomics, a biotechnology startup making crops hardier through chloroplast engineering, is pleased to announce the closing of an early Seed Round. Their technology will help farmers and seed companies meet current challenges facing agricultural...

St Louis Bioscience Startup Acquired at $100 Million Valuation

Confluence, a locally-grown company that was elevated, accelerated and incubated by BioGenerator, the investment arm of BioSTL, has been acquired by east coast biopharmaceutical company, Aclaris. The acquisition marks one of the most significant...

The Agile Mission of BioGenerator’s Grants Program

An idea is the start of a beautiful thing. But if you don’t have the means to test a theory, build a prototype or find out if there is even a market for your idea, how much good can it actually do? Enter BioGenerator's Grant Program.
BioSTL Fundamentals

How BioSTL Fundamentals is Elevating Early-Stage Entrepreneurs

"Fail fast" is more than a buzzword at BioSTL's Fundamentals program, which the organization started to help entrepreneurs identify and push past obstacles early on. Here's how the program is doing just that.
Karen Gheesling Mullis

RiverVest Closes $15 Million Biopharma Pre-Seed Fund, Says It Will Focus on Midwest Companies

Life sciences venture capital firm RiverVest Venture Partners today announced the closing of Archer Seed Fund, LP, at $15 million. Here's more about the firm's investment strategy.
Dr. Juan Arhancet, Apse

Why BioGenerator Works

Any entrepreneur can attest that the obstacles positioned between a brilliant idea and a successful, growing business are many. To startup founders working in the BioTech or life sciences field specifically, those roadblocks can be downright...
BioGenerator

Cultivation Capital’s Life Sciences Fund Finds Sweet Spot

Since its inception in 2013, Cultivation Capital’s Life Sciences Fund’s portfolio of 14 companies and one accelerator have raised $321M in total funding–with a $10.3M total dollar investment from the firm–while creating 180 jobs...
video

St. Louis Startup Accelerator Guide

We lay out the startup accelerator and startup incubator options for entrepreneurs based in St. Louis and those looking at what our city has to offer. Here's your Guide to Startup Accelerators in St....

Cultivation Capital Leads $1.2M Financing Round in S4

Cultivation Capital announced this morning that they have made an investment in S4, a data gathering and analytics company that provides risk management solutions to financial, agribusiness, and farming players through its algorithms. The St....

Founder Series: Steven Hanley of MediBeacon

MediBeacon is a name to know in the STL BioTech sector. The makers of proprietary, non-invasive, real-time monitoring systems for kidney function, gastrointestinal permeability and other light-activated diagnostics, MediBeacon acquired Mannheim Pharma & Diagnostics,...

Founder Series: Joseph Monahan of Confluence

When Pfizer left St. Louis in 2010, A small team of ex-Pfizer scientists with strong ideas for a new strategic approach to drug discovery research partnered with the St Louis BioGenerator leadership to develop a business...
BioGenerator Lab

Breaking Down BioGenerator

What is BioGenerator?  The short answer: A subsidiary of the non-profit organization BioSTL that was formed in 2003 to create, grow and invest in life science startups in the St. Louis region. The long answer: Their...

BioGenerator Company Accuronix Targets Pancreatic Cancer

Pancreatic Cancer causes 40,000 deaths each year, with available chemotherapy regimens providing only an average of 6-11 months survival. WashU-born company Accuronix, founded by Dr. William Hawkins and Robert Mach, PhD. (now of the...
STL Startup Funding

STL Startup Funding Guide

Million-dollar ideas need more than sweat equity to transform into a successful product or service. From accelerators supplying seed-level startup cash and mentorship to private equity firms offering hefty growth-stage investments, here’s a snapshot...
Bio STL Global STL EQ

International Affair

How BioSTL’s team is building a relationship with Israel’s startups to grow St. Louis’ ecosystem.

Disrupting Infection with Nanotechnology and Tom Cohen

Tom Cohen is founder of Nanopore Diagnostics, a St. Louis life science startup that's part of a new wave of companies bringing nanotechnology tools to today's challenges. They’re creating a clinical testing device to...

STL Startup News: Weekly Download – Dec. 11

Here’s a recap of STL startup news this week. Have news to share? Email us at editors@eqstl.com. Growth: Venture Café’s weekly happy hour gathering for entrepreneurs and innovators celebrated its 20,000th visitor on Thursday. The gatherings held at the @4240 building in...

Why All Wine Drinkers Will Love StiQit™

It used to be, if you had an adverse reaction to certain types of food or ingredients, your only option was avoidance, regardless of how much you loved it. Now, products created specifically for...

Can St. Louis Become the Next Bioscience Hub?

The growing list of bioscience companies bringing their research and operations to STL has forced many to take notice of the city’s place in the industry’s evolving landscape

BioGenerator Gets International Nod, Arch Angels Flying High, Appistry’s Samson vs Goliath Legal Battle

A compendium of St. Louis Startup news, celebrating America's most innovative entrepreneurs.

St. Louis Startup Scene: Gabe Lozano Hacks, Girls Ask Guys (Guys Say Yes), Sparo...

A compendium of St. Louis Startup news, celebrating America's most innovative entrepreneurs.

St. Louis Startup Scene: Capital Innovators Fund Five, DreamfundMe Makes It Personal, T-Rex Parties

From rapid expansion to a rooftop end-of-summer blowout, the St. Louis startup community moves onward and upward.

Startup Scene: BioGenerator Expands, SixThirty’s McKelvey Looks Overseas and Two VC’s Get Props For...

Startup news about BioGenerator's huge expansion, Cultivation Capital and Ascension Health's Big Dough, SixThirty's oversees search and more.

St. Louis Startup Scene: Square’s McKelvey Launches Launch Code, Showtime Signs On With LockerDome

News about Jim McKelvey's "game-changing" announcement, BioGenerator's new entrepreneurs, LockerDome's relationship with Showtime and more.